CVS Health Stock Price, News & Analysis (NYSE:CVS)

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Thursday, October 3rd. Investors of record on Thursday, October 24th will be given a dividend of $0.50 per share on Monday, November 4th. This represents a $2.00 annualized dividend and a dividend yield of 3.04%. The ex-dividend date is Wednesday, October 23rd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) posted its quarterly earnings data on Wednesday, August, 7th. The pharmacy operator reported $1.89 EPS for the quarter, beating analysts' consensus estimates of $1.70 by $0.19. The pharmacy operator earned $63.43 billion during the quarter, compared to the consensus estimate of $62.66 billion. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. CVS Health's quarterly revenue was up 35.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.69 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY19 earnings guidance on Wednesday, August, 7th. The company provided earnings per share guidance of $6.89-7.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.84.

27 equities research analysts have issued 12 month price targets for CVS Health's stock. Their forecasts range from $61.00 to $95.00. On average, they expect CVS Health's stock price to reach $75.39 in the next year. This suggests a possible upside of 14.6% from the stock's current price. View Analyst Price Targets for CVS Health.

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 1 sell rating, 7 hold ratings, 18 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Headlines about CVS stock have been trending somewhat positive this week, InfoTrie Sentiment reports. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. CVS Health earned a news impact score of 0.8 on InfoTrie's scale. They also gave news stories about the pharmacy operator a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Rite Aid (RAD), Petmed Express (PETS), 111 (YI), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Cisco Systems (CSCO), Johnson & Johnson (JNJ), NVIDIA (NVDA), Verizon Communications (VZ), Alibaba Group (BABA), Home Depot (HD), Intel (INTC) and Bank of America (BAC).

CVS Health's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Hexavest Inc. (0.09%), Strs Ohio (0.07%), Envestnet Asset Management Inc. (0.07%), Artemis Investment Management LLP (0.05%), Gateway Investment Advisers LLC (0.05%) and Atalanta Sosnoff Capital LLC (0.05%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Rothschild Investment Corp IL, State of Alaska Department of Revenue, CIBC Private Wealth Group LLC, Hexavest Inc., Nisa Investment Advisors LLC, Rhenman & Partners Asset Management AB, Gateway Investment Advisers LLC and Verity & Verity LLC. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Larry J Merlo and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was bought by a variety of institutional investors in the last quarter, including Artemis Investment Management LLP, Polaris Greystone Financial Group LLC, Atalanta Sosnoff Capital LLC, Assenagon Asset Management S.A., Country Trust Bank, CHURCHILL MANAGEMENT Corp, Strs Ohio and Commerzbank Aktiengesellschaft FI. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $65.77.

CVS Health has a market capitalization of $85.53 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]